According to the IMARC Group, the lichen planus market reached a value of US$ 91.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 139.4 Million by 2034, exhibiting a growth rate (CAGR) of 3.95% during 2024-2034. This can be attributed to the growing use of topical targeted therapy due to its several advantages, including improved patient compliance and lesion-specific treatment.Lichen planus is a chronic inflammatory medical condition that primarily affects the mucous membranes, skin, hair, and nails. The lichen planus market is witnessing notable growth due to various market drivers. Primarily, the increasing prevalence of lichen planus, a chronic inflammatory condition affecting skin and mucous membranes, significantly contributes to market expansion. Moreover, advancements in medical research and technology have led to the development of new therapeutic approaches. Additionally, increased awareness about the disease among healthcare professionals and patients promotes early diagnosis and intervention, thereby improving patient outcomes and boosting market growth. Furthermore, the lichen planus market is benefiting from substantial investments by pharmaceutical companies in R&D activities aimed at discovering new treatments and improving existing ones. In addition, the increasing trend of personalized medicine, which tailors therapy programs to unique patient profiles, plays an essential part in the market's rise. This approach enhances treatment efficacy and patient satisfaction, thereby encouraging market expansion. Meanwhile, the market is expected to expand further due to the continuous advancements in diagnostic techniques, which enable more accurate and earlier detection of lichen planus.
Request for a sample of this report: https://www.imarcgroup.com/lichen-planus-market/requestsample
Countries Covered:
• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country:
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Lichen Planus Market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Lichen Planus Market
• Reimbursement scenario in the market
• In-market and pipeline drugs
This report also provides a detailed analysis of the current Lichen Planus Market drugs and late-stage pipeline drugs.
In-Market Drugs:
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
Competitive Landscape with key players:
The competitive landscape of the Lichen Planus Market has been studied in the report with the detailed profiles of the key players operating in the market.
1. AFYX Therapeutics
2. Incyte Corporation/Novartis
Ask the Analyst for Customization and Explore the Full Report with TOC: https://www.imarcgroup.com/lichen-planus-market
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No